Administration de la santé publique : Questions médicales fréquentes
Nom anglais: Public Health Administration
Descriptor UI:D011635
Tree Number:N04.452.794
Termes MeSH sélectionnés :
Chorionic Villi Sampling
Questions fréquentes et termes MeSH associés
Diagnostic
2
#1
Comment évaluer l'efficacité d'un programme de santé publique ?
L'efficacité se mesure par des indicateurs de santé, des enquêtes et des analyses de données.
Évaluation des programmesSanté publique
#2
Quels outils sont utilisés pour le diagnostic en santé publique ?
Des enquêtes épidémiologiques, des statistiques de santé et des études de cohorte sont utilisés.
ÉpidémiologieStatistiques de santé
Symptômes
2
#1
Quels symptômes indiquent un problème de santé publique ?
Des épidémies, des taux de mortalité élevés et des maladies infectieuses en hausse sont des indicateurs.
ÉpidémiesMaladies infectieuses
#2
Comment les symptômes de maladies affectent-ils la santé publique ?
Ils influencent les politiques de santé, la prévention et les ressources allouées aux soins.
Politiques de santéPrévention des maladies
Prévention
2
#1
Quelles stratégies de prévention sont efficaces ?
Les campagnes de vaccination, l'éducation à la santé et les politiques de santé publique sont efficaces.
Éducation à la santéCampagnes de vaccination
#2
Comment la prévention est-elle mesurée ?
Elle est mesurée par la réduction des cas de maladies, l'augmentation des vaccinations et des dépistages.
DépistagePrévention des maladies
Traitements
2
#1
Quels traitements sont prioritaires en santé publique ?
Les vaccinations, les traitements des maladies infectieuses et la santé maternelle sont prioritaires.
VaccinationSanté maternelle
#2
Comment les traitements sont-ils administrés en santé publique ?
Ils sont souvent fournis par des programmes de santé communautaire et des campagnes de sensibilisation.
Programmes de santéSensibilisation
Complications
2
#1
Quelles complications peuvent survenir sans intervention en santé publique ?
Des épidémies, des résistances aux antibiotiques et des maladies chroniques peuvent survenir.
Résistance aux antibiotiquesMaladies chroniques
#2
Comment les complications affectent-elles les systèmes de santé ?
Elles augmentent la charge sur les systèmes de santé, nécessitant plus de ressources et de personnel.
Systèmes de santéRessources en santé
Facteurs de risque
2
#1
Quels sont les principaux facteurs de risque en santé publique ?
Les comportements à risque, la pauvreté et l'accès limité aux soins sont des facteurs clés.
Comportements à risqueAccès aux soins
#2
Comment identifier les facteurs de risque dans une population ?
Par des études épidémiologiques, des enquêtes et des analyses de données démographiques.
Analyse démographiqueÉtudes épidémiologiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Administration de la santé publique : Questions médicales les plus fréquentes",
"headline": "Administration de la santé publique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Administration de la santé publique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-23",
"dateModified": "2025-02-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Administration de la santé publique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Organisation et administration",
"url": "https://questionsmedicales.fr/mesh/D009934",
"about": {
"@type": "MedicalCondition",
"name": "Organisation et administration",
"code": {
"@type": "MedicalCode",
"code": "D009934",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Administration de la santé publique",
"alternateName": "Public Health Administration",
"code": {
"@type": "MedicalCode",
"code": "D011635",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stephen Thomson",
"url": "https://questionsmedicales.fr/author/Stephen%20Thomson",
"affiliation": {
"@type": "Organization",
"name": "ANU College of Law, The Australian National University, Canberra, Australia. stephen.thomson@anu.edu.au."
}
},
{
"@type": "Person",
"name": "Muhammad Zia Ud Din",
"url": "https://questionsmedicales.fr/author/Muhammad%20Zia%20Ud%20Din",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China."
}
},
{
"@type": "Person",
"name": "Xu Yuan Yuan",
"url": "https://questionsmedicales.fr/author/Xu%20Yuan%20Yuan",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. xuyuanyuanj@163.com."
}
},
{
"@type": "Person",
"name": "Naqib Ullah Khan",
"url": "https://questionsmedicales.fr/author/Naqib%20Ullah%20Khan",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. naqibkhan05@csu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Foetal loss after chorionic villus sampling and amniocentesis in twin pregnancies: A multicentre retrospective cohort study.",
"datePublished": "2022-09-27",
"url": "https://questionsmedicales.fr/article/36097373",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pd.6237"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characteristic DNA methylation profiles of chorionic villi in recurrent miscarriage.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35896560",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-15656-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Histomorphometric study of placental blood vessels of chorion and chorionic villi vascular area among women with preeclampsia.",
"datePublished": "2022-05-18",
"url": "https://questionsmedicales.fr/article/35635853",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.placenta.2022.05.011"
}
},
{
"@type": "ScholarlyArticle",
"name": "How does cell-based non-invasive prenatal test (NIPT) perform against chorionic villus sampling and cell-free NIPT in detecting trisomies and copy number variations? A clinical study from Denmark.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37199490",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pd.6387"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between HIF-1α, BNIP3, and autophagy in the chorionic villi of missed abortion.",
"datePublished": "2023-05-07",
"url": "https://questionsmedicales.fr/article/37150840",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jog.15667"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Administration de la santé publique",
"item": "https://questionsmedicales.fr/mesh/D011635"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Administration de la santé publique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Administration de la santé publique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Administration de la santé publique",
"description": "Comment évaluer l'efficacité d'un programme de santé publique ?\nQuels outils sont utilisés pour le diagnostic en santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Chorionic+Villi+Sampling#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Administration de la santé publique",
"description": "Quels symptômes indiquent un problème de santé publique ?\nComment les symptômes de maladies affectent-ils la santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Chorionic+Villi+Sampling#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Administration de la santé publique",
"description": "Quelles stratégies de prévention sont efficaces ?\nComment la prévention est-elle mesurée ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Chorionic+Villi+Sampling#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Administration de la santé publique",
"description": "Quels traitements sont prioritaires en santé publique ?\nComment les traitements sont-ils administrés en santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Chorionic+Villi+Sampling#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Administration de la santé publique",
"description": "Quelles complications peuvent survenir sans intervention en santé publique ?\nComment les complications affectent-elles les systèmes de santé ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Chorionic+Villi+Sampling#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Administration de la santé publique",
"description": "Quels sont les principaux facteurs de risque en santé publique ?\nComment identifier les facteurs de risque dans une population ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Chorionic+Villi+Sampling#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un programme de santé publique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité se mesure par des indicateurs de santé, des enquêtes et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic en santé publique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes épidémiologiques, des statistiques de santé et des études de cohorte sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de santé publique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des épidémies, des taux de mortalité élevés et des maladies infectieuses en hausse sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment les symptômes de maladies affectent-ils la santé publique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils influencent les politiques de santé, la prévention et les ressources allouées aux soins."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de vaccination, l'éducation à la santé et les politiques de santé publique sont efficaces."
}
},
{
"@type": "Question",
"name": "Comment la prévention est-elle mesurée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est mesurée par la réduction des cas de maladies, l'augmentation des vaccinations et des dépistages."
}
},
{
"@type": "Question",
"name": "Quels traitements sont prioritaires en santé publique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations, les traitements des maladies infectieuses et la santé maternelle sont prioritaires."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils administrés en santé publique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent fournis par des programmes de santé communautaire et des campagnes de sensibilisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans intervention en santé publique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des épidémies, des résistances aux antibiotiques et des maladies chroniques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles les systèmes de santé ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles augmentent la charge sur les systèmes de santé, nécessitant plus de ressources et de personnel."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque en santé publique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements à risque, la pauvreté et l'accès limité aux soins sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Comment identifier les facteurs de risque dans une population ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études épidémiologiques, des enquêtes et des analyses de données démographiques."
}
}
]
}
]
}
Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, North Carolina (Dr Little); and North Carolina Health Care Facilities Association, Raleigh, North Carolina (Ms Welsh and Dr Sholar).
Publications dans "Administration de la santé publique" :
We aimed to determine foetal losses for DCDA and MCDA twins following transabdominal CVS or amniocentesis performed <22+...
Retrospective cohort study conducted in the UK and Belgium 01/01/00-01/06/20. Cases with unknown chorionicity, monochorionic complications or complex procedures were excluded. Uncomplicated DCDA and M...
Outcomes were compared for DCDA foetuses; 258 after CVS with 3406 controls, 406 after amniocentesis with 3390 controls plus MCDA foetuses, 98 after CVS with 1124 controls, and 160 after amniocentesis ...
This study indicates increased foetal losses for DCDA and MCDA twins following CVS and amniocentesis with uncertain risk to normal foetuses....
Dysregulation of transcriptional programs that are tightly regulated by DNA methylation during placental and fetal development at different gestational stages, may cause recurrent miscarriage. Here, w...
The direction of blood movement in normal and abnormal placenta is curious from a morphometric point of view. Once pregnancy is compromised by an illness like hypertension, maternal and foetal distres...
Measurements used a computerized morphometry system and a Vascular Medicine Institute (VMI) calculator....
Our data showed a significant decrease in vessel area (VA), wall area (WA), lumen area (LA), mean wall thickness-boundary (MWTB), mean wall thickness-rosette (MWTR), mean diameter-rosette (MDR), mean ...
We concluded that preeclamptic chorion and chorionic villi vessels are linked with significant structural discrepancies; future studies should address morphological events that occur throughout pregna...
We aimed to compare cell-based NIPT (cbNIPT) to chorionic villus sampling (CVS) and to examine the test characteristics of cbNIPT in the first clinical validation study of cbNIPT compared to cell-free...
Study 1: Women (N = 92) who accepted CVS were recruited for cbNIPT (53 normal and 39 abnormal). Samples were analyzed with chromosomal microarray (CMA). Study 2: Women (N = 282) who accepted cfNIPT we...
Study 1: cbNIPT detected all aberrations (32/32) found in CVS: trisomies 13, 18 and 21 (23/23), pathogenic copy number variations (CNVs) (6/6) and sex chromosome aberrations (3/3). cbNIPT detected 3/8...
Circulating trophoblasts in the maternal circulation provide the potential of screening for aneuploidies and pathogenic CNVs covering the entire fetal genome....
To investigate the expression of autophagy mediated by the hypoxia-inducible factor 1α (HIF-1α)/BNIP3 signaling pathway in villus tissues of missed abortion and HTR-8/SVneo cells and to elucidate the ...
Villus tissues from 30 healthy women with induced abortion and 35 patients with missed abortion were collected, and HTR-8/SVneo cells were cultured under hypoxia and transfected with HIF-1α-siRNA. Rea...
The mRNA levels of HIF-1α and BNIP3 were significantly lower in the missed abortion villi than in the induced abortion samples. The protein levels of HIF-1α, BNIP3, Beclin 1, and LC3II/I were signific...
Autophagy mediated by the HIF-1α/BNIP3 signaling pathway in villous trophoblast cells may be associated with the progression and development of missed abortion....
An important step in the proteomic analysis of missing proteins is the use of a wide range of tissues, optimal extraction, and the processing of protein material in order to ensure the highest sensiti...
The placenta is important for fetal development in mammals, and spatial transcriptomic profiling of placenta helps to resolve its structure and function. In this study, we described the landscape of s...
Growing data suggest a role of Treg cells in placentation. The aim of the study was to evaluate Treg cells (FOXP3-positive cells) placental bed infiltration in patients with placenta accrete syndrome ...
The study group included 13 patients with PAS and the control group consisted of 66 women who had caesarean (CD) delivery of whom, 44 patients with elective caesarean (EC) delivery, and 22 patients wi...
We observed significant difference in the degree of FOXP3-positive cell CV infiltration between studied groups (p = 0.04). FOXP3-positive cells were the most commonly observed in PAS patients, while, ...
Our study provides further evidence that abnormal invasive placentation is an associated disturbance of the maternal immune response. Accordingly, we have theorized that alteration of the FOXP3-positi...
The relationship between fertility and maternal body weight is shaped like an inverted "U," meaning that fertility is negatively affected in overweight or underweight women. Timely and appropriate mat...
Mosaic chromosomal anomalies arising in the product of conception and the final fetal chromosomal arrangement are expression of complex biological mechanisms. The rescue of unbalanced chromosome with ...
